In the case of PV suspicion, JAK2-V617F mutation, serum erythropoietin levels, bone marrow biopsy, and cytogenetics are performed by 100%, 83.9%, 77.4%, and 51.6% of respondents, respectively. The gene discussed is JAK2; the disease is acquired polycythemia vera.